Accretive Health prices initial public offering at $12.00 per share

Accretive Health, Inc. (NYSE:AH), a provider of end-to-end revenue cycle management services for U.S. healthcare providers today announced the initial public offering of 10,000,000 shares of its common stock at a price to the public of $12.00 per share. Of the 10,000,000 shares being offered to the public, 6,666,667 shares are being offered by Accretive Health and 3,333,333 shares are being offered by selling stockholders. In addition, the underwriters have a 30-day option to purchase up to an additional 1,500,000 shares. Accretive Health's common stock is expected to begin trading on the New York Stock Exchange under the symbol "AH" on May 20, 2010.

Goldman, Sachs & Co., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities Inc. and Morgan Stanley & Co. Incorporated are joint book runners for the offering. Robert W. Baird & Co. Incorporated and William Blair & Company, L.L.C. are acting as co-managers of the offering.

Source:

Accretive Health

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How Fluidics is Powering Modern Healthcare and Medical Device Innovation